m+Medelevator.RU
← Поиск публикаций
Abdominal radiology (New York) · 2024

A multimodal deep-learning model based on multichannel CT radiomics for predicting pathological grade of bladder cancer.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhao Ting, He Jian, Zhang Licui, Li Hongyang, Duan Qinghong

Аннотация

OBJECTIVE: To construct a predictive model using deep-learning radiomics and clinical risk factors for assessing the preoperative histopathological grade of bladder cancer according to computed tomography (CT) images.

METHODS: A retrospective analysis was conducted involving 201 bladder cancer patients with definite pathological grading results after surgical excision at the organization between January 2019 and June 2023. The cohort was classified into a test set of 81 cases and a training set of 120 cases. Hand-crafted radiomics (HCR) and features derived from deep-learning (DL) were obtained from computed tomography (CT) images. The research builds a prediction model using 12 machine-learning classifiers, which integrate HCR, DL features, and clinical data. Model performance was estimated utilizing decision-curve analysis (DCA), the area under the curve (AUC), and calibration curves.

RESULTS: Among the classifiers tested, the logistic regression model that combined DL and HCR characteristics demonstrated the finest performance. The AUC values were 0.912 (training set) and 0.777 (test set). The AUC values of clinical model achieved 0.850 (training set) and 0.804 (test set). The AUC values of the combined model were 0.933 (training set) and 0.824 (test set), outperforming both the clinical and HCR-only models.

CONCLUSION: The CT-based combined model demonstrated considerable diagnostic capability in differentiating high-grade from low-grade bladder cancer, serving as a valuable noninvasive instrument for preoperative pathological evaluation.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты